American Portfolios Advisors Alnylam Pharmaceuticals, Inc. Transaction History
American Portfolios Advisors
- $2.36 Trillion
- Q3 2022
A detailed history of American Portfolios Advisors transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, American Portfolios Advisors holds 30 shares of ALNY stock, worth $8,394. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30Holding current value
$8,394% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
641Shares Held
108MCall Options Held
2.11MPut Options Held
2.04M-
Capital World Investors Los Angeles, CA15MShares$4.19 Billion0.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.5MShares$3.5 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.67 Billion0.05% of portfolio
-
Wellington Management Group LLP Boston, MA6.21MShares$1.74 Billion0.28% of portfolio
-
Baillie Gifford & CO4.89MShares$1.37 Billion1.03% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $34.4B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...